Cambrex Bio Science Walkersville

Cambrex Bio Science Walkersville was a leading provider of products and services for the life sciences industry, specializing in cell biology, endotoxin detection, and biomanufacturing. The company was a key division of Cambrex Corporation until its acquisition by Lonza Group in 2007 for approximately 460 million dollars. Following the acquisition, the entity was integrated into Lonza's Bioscience and Cell & Gene Therapy divisions. The Walkersville facility is well-known for its production of high-quality cell culture media, reagents, and the Nucleofector transfection technology. It also serves as a major contract development and manufacturing organization (CDMO) site for cell and gene therapies. Today, the site continues to operate as a vital hub for Lonza's global bioprocessing and research tools business.